Business
New appointments
New appointments.
About this update from Optibiotix Health Plc
[{"type":"text","content":"\n \n \n \n RNS Number : 0900M\n OptiBiotix Health PLC\n 19 January 2021\n \n \n \n OptiBiotix Health plc\n \n \n (\n \n \"OptiBiotix\" or \"the Company\")\n \n \n \n New appointments\n \n \n \n OptiBiotix Health plc (AIM: OPTI), a life sciences business developing compounds to tackle obesity, high cholesterol and diabetes, announces the appointment of Dr Taru Jain \n as Business Development Director in Asia\n and Christopher Nother\n , as the pharmaceutical lead on LPLDL®.\n \n \n \n \n Christopher Nother is joining OptiBiotix on a part time consultancy basis to support the growth of LPLDL® in pharma, either as an 'over the counter' (OTC) product used by itself or in combination with existing treatments (e.g. statins), or a drug biotherapeutic in markets outside the USA. Chris joins OptiBiotix after leading global business development at Nypro Healthcare's (now Jabil Healthcare) Pharmaceutical Delivery Systems division. Jabil Healthcare describes itself as the world's leading healthcare contract manufacturing organisation on its website, and its parent company, Jabil Inc., is a Fortune 200 world leading manufacturing solutions provider. Chris advises a number of other businesses in the healthcare and drug delivery systems sectors and is Interim CEO at Surgical Synergy Limited.\n \n \n Dr Taru Jain will join OptiBiotix's management team in March 2021 to focus on business development and growing sales in the strategically important Indian and Asian markets. Dr. Taru was previously the Executive Director at Akums Drugs & Pharmaceuticals Ltd, (Akums website states it is India's single largest Contract Research and Manufacturing (CRAMS) organisation responsible for manufacturing approximately 11-12% of all drugs consumed in the country). Her responsibilities at Akums included in-licensing worldwide, marketing strategy and design, client and account relationship management, along with representation of the company on national and international forums. She has over 10 years of experience across the Indian healthcare value chain as well as primary knowledge of the demand pattern of the prescription and OTC market.\n \n \n \n Stephen OHara CEO of OptiBiotix Health plc \n \n \n c\n \n \n o\n \n \n m\n...